FDA Approval Activities for this Drug…
Alavert (loratadine) Orally Disintegrating Tablets, () Whitehall-Robbins NDA 21-375 12/12/02
Alavert (loratadine) Orally Disintegrating Tablets, OTC Wyeth Consumer Healthcare NDA 21-375 Claritin (loratadine) Tablets, Syrup and RediTabs, OTC Schering NDA 19-658/S-018, 20-704/S-008, & 20-641/S-009 11/27/02 12/6/02
Claritin (Loratadine) Syrup, Schering NDA 20-641/S7 12/4/00 5/16/02 5/16/02 5/16/02
Claritin (Loratadine) Tablet, Schering NDA 19658/S21 6/25/03 7/6/03
Claritin (loratadine/pseudoephedrine sulfate) D-12 and D-24 Extended Release Tablets, OTC Schering NDA 19-670/S-018 & 20-470/S-016 11/27/02 12/6/02
Claritin-D24 Hour (10 mg loratadine/240 mg pseudoephedrine sulfate, USP) Extended Release Tablets Schering NDA 20-470/S005 12/4/98 5/23/01
Claritin-D 24 Hour (10 mg loratadine/240 mg pseudoephedrine sulfate, USP) Extended Release Tablets Schering NDA 20-470/S19 Loratadine Syrup, 10 mg/10 mL, Taro ANDA 76-127 6/26/02
Loratadine Syrup, 10 mg/10 mL, OTC L. Perrigo Co. ANDA 75-728 3/12/03
Loratadine Syrup, 10 mg/10 mL, Novex Pharma ANDA 75-565 7/30/01
Loratadine Orally Disintegrating Tablets, 10 mg, OTC Impax ANDA 76-011 9/29/03
Loratadine Orally Disintegrating Tablets, 10 mg, Wyeth Consumer Healthcare ANDA 75-822 2/10/03 2/14/03
Loratadine Orally Disintegrating Tablets, 10 mg, Andrx ANDA 75-990 11/15/02
Loratadine Tablets, 10 mg, OTC Geneva ANDA 75-209 1/21/03 2/14/03
Loratadine Tablets, 10 mg, Geneva ANDA 75-209 9/13/01
Loratadine Tablets, 10 mg, Genpharm ANDA 76-154 8/20/03
Loratadine Tablets, 10 mg, Genpharm ANDA 76-154 2/28/02 4/11/03
Loratadine Tablets, 10 mg, Ranbaxy Ltd. ANDA 76-134 8/18/03
Loratadine Tablets, 10 mg, Ranbaxy Ltd. ANDA 76-134 12/20/01 4/16/03
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 5 mg/120 mg, Andrx L.L.C. ANDA 76-208 2/24/03
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 5 mg/120 mg, Impax, ANDA 76-050 1/30/03 2/14/03
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 5 mg/120 mg, Impax, ANDA 76-050 5/29/02
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 10 mg/240 mg, Impax, ANDA 75-989 5/24/02
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 10 mg/240 mg, Andrx L.L.C. ANDA 75-706 2/21/03
Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, 10 mg/240 mg, Andrx L.L.C. ANDA 75-706 7/9/02
Loratadine Tablets, 10 mg, Mylan ANDA 75-790 1/12/01 3/5/01
Loratadine Tablets, 10 mg, Mylan ANDA 75-790 1/12/01 3/5/01
Loratadine Tablets, 10 mg, Teva USA ANDA 75-722 Loratadine Orally Disintegrating Tablets, Andrx Loratadine Syrup, Teva Claritin (Loratadine) Tablet, Reditab & Syrup, Schering Loratadine Syrup, Morton Grove Pharmaceuticals, Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, Andrx Pharmaceuticals, L.L.C. Loratadine and Pseudoephedrine Sulfate Extended-release Tablets, Impax Laboratories, Inc. Loratadine Syrup, Novex Pharma, Loratadine Tablets, Perrigo Company Loratadine Tablets USP, L. Perrigo Company, Approval Claritin (loratadine) Syrup, Schering Corporation, Package Change
Claritin-D 24 Hour (10 mg loratadine and 240 mg pseudoephedrine sulfate) Extended Release Tablets, Schering-Plough, Labeling Revision Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate) Extended Release Tablets, Schering-Plough, New or Modified Indication
Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) Extended Release Tablets, Schering-Plough, New or Modified Indication Loratadine Syrup, L.Perrigo Co., Approval
Loratadine Syrup, Morton Grove Pharma, Approval
Loratadine Syrup, Ranbaxy Laboratories Ltd., Approval
Loratadine Syrup, Taro Pharmaceutical, Approval
For the latest approval information, locate this drug using this index.
